Abstract
<h3>In Reply.—</h3> The Lederle authors, describing our research as "incomplete," cite two articles that they believe we have overlooked. The amoxapine overdose series of Kulig et al,<sup>1</sup>however, was cited in our manuscript but never mentions a higher convulsion rate compared with other cyclic antidepressants despite the occurrence of seizures in 100% of the reported patients. Another letter by two of the correspondents<sup>2</sup>had not yet been published when our manuscript was submitted but does state that "convulsive seizures after an overdose, although not uncommon with the older TCAs [tricyclic antidepressants], may be more common with amoxapine." Our study populations included all cases reported to the two poison control centers during the 18-month study period. We are unable to identify any reporting bias favoring more severe amoxapine cases as compared with other cyclic antidepressants. Our data include a slightly but not significantly higher percentage of pediatric ingestions in
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: JAMA: The Journal of the American Medical Association
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
